Top Upgrades
- Raymond James upgraded American Airlines Group Inc AAL from Market Perform to Outperform. American Airlines shares gained 0.65 percent to $44.67 in pre-market trading.
- Analysts at Morgan Stanley upgraded Pfizer Inc. PFE from Equal-Weight to Overweight. Pfizer shares gained 0.96 percent to $35.79 in pre-market trading.
- Credit Suisse upgraded Progressive Corp PGR from Underperform to Neutral. Progressive shares rose 2.85 percent to close at $47.63 on Tuesday.
- Susquehanna upgraded Hibbett Sports, Inc. HIBB from Neutral to Positive. Hibbett shares closed at $13.15 on Tuesday.
- BMO Capital upgraded Post Holdings Inc POST from Market Perform to Outperform. Post Holdings shares rose 0.61 percent to close at $86.36 on Tuesday.
- Argus upgraded Bioverativ Inc BIVV from Hold to Buy. Bioverativ shares rose 0.50 percent to close at $56.39 on Tuesday.
- Analysts at JP Morgan upgraded Dover Corp DOV from Neutral to Overweight. Dover shares rose 1.01 percent to close at $90.96 on Tuesday.
- Morgan Stanley upgraded Arista Networks Inc ANET from Equal-Weight to Overweight. Arista Networks shares fell 0.53 percent to close at $181.72 on Tuesday.
- Analysts at Raymond James upgraded Southwest Airlines Co LUV from Market Perform to Outperform. Southwest shares rose 1.79 percent to $54.50 in pre-market trading.
Top Downgrades
- Raymond James downgraded United Continental Holdings Inc UAL from Outperform to Market Perform. United Continental shares declined 0.31 percent to $57.36 in pre-market trading.
- Cowen & Co. downgraded L Brands Inc LB from Outperform to Market Perform. L Brands shares slipped 1.88 percent to close at $39.23 on Tuesday.
- Wedbush downgraded Signature Bank SBNY from Outperform to Neutral. Signature Bank shares gained 0.18 percent to close at $120.15 on Tuesday.
- Jefferies downgraded TransDigm Group Incorporated TDG from Buy to Hold. TransDigm shares gained 0.21 percent to close at $265.20 on Tuesday.
- Analysts at JP Morgan downgraded 3M Co MMM from Neutral to Underweight. 3M shares declined 1.43 percent to $210.50 in pre-market trading.
- Morgan Stanley downgraded Allergan plc AGN from Overweight to Equal-Weight. Allergan shares declined 1.16 percent to $212.50 in pre-market trading.
- Analysts at Raymond James downgraded Tintri Inc TNTR from Outperform to Underperform. Tintri shares dropped 10.95 percent to close at $3.66 on Tuesday.
- JP Morgan downgraded Ingersoll-Rand PLC IR from Overweight to Neutral. Ingersoll-Rand shares slipped 0.06 percent to close at $90.46 on Tuesday.
Top Initiations
- Analysts at Credit Suisse initiated coverage on Vistra Energy Corp VST with an Outperform rating. The price target for Vistra Energy is set to $20. Vistra Energy shares closed at $17.88 on Tuesday.
- Analysts at Barclays initiated coverage of Ralph Lauren Corp RL with an Underweight rating. The price target for Ralph Lauren is set to $84. Ralph Lauren shares closed at $91.03 on Tuesday.
- Argus initiated coverage on Intuit Inc. INTU with a Buy rating. The price target for Intuit is set to $165. Intuit shares closed at $145.34 on Tuesday.
- Jefferies initiated coverage on Epizyme Inc EPZM with a Buy rating. The price target for Epizyme is set to $23. Epizyme shares closed at $19.25 on Tuesday.
- Barclays initiated coverage on PVH Corp PVH with an Overweight rating. The price target for PVH is set to $147. PVH shares closed at $127.47 on Tuesday.
- Buckingham initiated coverage on Electronic Arts Inc. EA with a Buy rating. Electronic Arts shares closed at $120.21 on Tuesday.
- Analysts at Cantor Fitzgerald initiated coverage on CymaBay Therapeutics Inc CBAY with an Overweight rating. The price target for CymaBay Therapeutics is set to $16. CymaBay Therapeutics shares closed at $6.99 on Tuesday.
- Analysts at SunTrust Robinson Humphrey initiated coverage on Biogen Inc BIIB with a Buy rating. The price target for Biogen is set to $360. Biogen closed at $317.93 on Tuesday.
- Analysts at Barclays initiated coverage on Coach Inc COH with an Equal-Weight rating. The price target for Coach is set to $45. Coach shares closed at $40.35 on Tuesday.
- KeyBanc initiated coverage of Evolent Health Inc EVH with an Overweight rating. The price target for Evolent Health is set to $23. Evolent Health shares closed at $15.65 on Tuesday.
ANETArista Networks Inc
$114.496.17%
BIIBBiogen Inc
$146.231.26%
DOVDover Corp
$205.344.04%
EAElectronic Arts Inc
$118.301.03%
EVHEvolent Health Inc
$10.581.63%
INTUIntuit Inc
$604.601.96%
IRIngersoll Rand Inc
$92.631.57%
LBLandBridge Co LLC
$64.14-5.82%
LUVSouthwest Airlines Co
$31.43-0.70%
MMM3M Co
$154.401.89%
PFEPfizer Inc
$26.870.94%
PGRProgressive Corp
$249.221.14%
POSTPost Holdings Inc
$107.751.13%
PVHPVH Corp
$92.991.33%
RLRalph Lauren Corp
$257.000.07%
SBNYSignature Bank
$1.23-8.89%
TDGTransDigm Group Inc
$1364.891.94%
UALUnited Airlines Holdings Inc
$109.451.10%
VSTVistra Corp
$178.4014.9%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in